Biotech

All Articles

Lundbeck slashes value of $250M Abide buyout after ache trouble

.Lundbeck is lowering the book market value of its own $250 million Abide Therapies acquistion in ac...

Real- World Data Complies With Professional Test Layout: Maximizing Process and also Internet Site Selection

.The combination of real-world information (RWD) in to procedure usefulness and web site choice has ...

Where are they now? Catching up with past Fierce 15 guest of honors

.At this year's Tough Biotech Top in Boston ma, our company caught up with leaders in the biotech bu...

Merck grabs preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually taking down $30 thousand in advance to buy Yale spinout Modifi Bioscienc...

Radiopharma Alpha-9 elevates $175M set C to fund scientific push

.Alpha-9 Oncology has actually raised a $175 thousand collection C cycle to stake its own clinical-s...

Ocuphire to completely transform into genetics treatment biotech through Piece purchase

.Eye medicine producer Ocuphire Pharma is getting genetics therapy programmer Piece Genetic makeup i...

Roche culls cough prospect, turns KRAS program in Q3 update

.Roche's severe coughing plan has sputtered to a standstill. The drugmaker, which axed the plan afte...

Merck- Gilead long-acting dental combination suppresses HIV for 48 weeks

.Gilead Sciences and Merck &amp Co. have assisted their once-weekly HIV combination treatment past y...

Lykos accepts FDA view that MDMA approval depends on fresh test

.Lykos Therapies might possess shed three-quarters of its team following the FDA's being rejected of...

Septerna intends $158M IPO to finance readouts for GPCR pipe

.Septerna might be yet to make known "any purposeful professional data," however the biotech clearly...